Genetic Technologies Announces Offering of Approximately USD 1.2 Million of American Depository Shares
Nasdaq: GENE, “Company”), a diversified molecular diagnostics company, today announced that it has entered into a securities purchase agreement with certain accredited institutional investors, pursuant...
Genetic Tech down 12% on private capital raise
Nano cap Genetic Technologies ( GENE -11.7% ) is down, albeit on below-average volume, in reaction to its direct sale of ~1.5M ADSs at $0.80 per ADS to institutional investors. Gross proceeds should...
Genetic Technologies Interview to Air on Bloomberg International on the RedChip Money Report
MELBOURNE, Australia, May 17, 2019 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce an interview with its Chairman.
TME and SLDB among premarket losers
Solid Biosciences (NASDAQ: SLDB ) -41% on potential safety signals for DMD gene therapy. More news on: Solid Biosciences Inc., Myovant Sciences Ltd., InspireMD, Inc., Stocks on the move, Read more...
Genetic Technologies Limited (ASX Code: GTG; NASDAQ Ticker: GENE) announces successful completion of two ne
NASDAQ Ticker: GENE) is delighted to announce that following substantial scientific research and genetic product development, two new ground-breaking cancer risk assessment tests have now been completed...
Genetic Technologies Receives Nasdaq Notification Letter
MELBOURNE, Australia, May 03, 2019 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) announces that it has received a letter from the.
Genetic Technologies and The Translational Genomics Research Institute of Phoenix, Arizona Sign Memorandum
Genetic Technologies Limited (ASX:GTG) (GENE) (“Company”), a provider of world-leading genetic risk assessment test products, is pleased to announce that it has now established a Memorandum of Understanding...
Genetic Technologies Asian Operations Established in Hainan, China
Highlights Genetic Technologies establishes Asian operations in China.The move into Asia includes the formation of Genetic Technologies HK Limited and Hainan Aocheng Genetic.
Genetic Technologies Limited Announces Research Collaboration with Two World-Renowned Medical Centres
MELBOURNE, Australia, Feb. 01, 2019 -- Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”), a diversified molecular diagnostics company is pleased to announce the.
Biotechs up out the gate on Lilly/Loxo tie-up and start of JPM19
Healthcare investors are enjoying a rousing start to the week after Eli Lilly announced its takeover of Loxo Oncology and the release of a multitude of preliminary 2018 results for presenters at JPMorgan's...
THE CANNABIS COMPANY
Our development has always been toward the future, when the cannabis industry fully opens up into a regulated consumer market on October 17, 2018. With a legislative head start in Canada, we have quickly secured one of the strongest cultivation profiles in the country, supported by over 250 acres of production capacity. All our licensed producers operate under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and share a common dedication to quality, consistency and safety.
Agile development is at the core of who we are
From the beginning, we have moved quickly to gain an advantage when it comes to the production of cannabis. Our strength comes from our ability to rapidly adjust to the shifting sector and market while executing growth strategies based on lean principles.
Legal cannabis is not an easy industry to navigate. As a team, Invictus has built a solid knowledge base with every plan, project and permit successfully achieved over the years. Our familiarity with the burgeoning cannabis industry, combined with our agile approach, is what powers our business and development.